Collection of Circulating Biomarkers in Pancreatic Cancer

Abramson Cancer Center at Penn Medicine

Status: Enrolling

Conditions: Pancreas Cancer

Treatments: Other: Obtaining blood for analysis of various circulating biomarkers

Study type: Observational

Funder types: Other

Identifiers

NCT05743049

UPCC 20222

852628 (Other Identifier)

Details and patient eligibility

About

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Enrollment: 30 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma
• The subject must be a patient of the University of Pennsylvania
• The subject must be able to provide informed consent
• The subject must be 18 years of age or older

Exclusion criteria

. Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.

Trial design

30 participants in 1 patient group

Blood specimens

Description:

Collection of blood for analysis of various circulating biomarkers in patients with pancreatic adenocarcinoma.

Treatment:

Other: Obtaining blood for analysis of various circulating biomarkers